Evidence-Based Nanoscopic and Molecular Framework for Excipient Functionality in Compressed Orally Disintegrating Tablets

被引:16
作者
Al-khattawi, Ali [1 ,3 ]
Alyami, Hamad [1 ]
Townsend, Bill [2 ,3 ]
Ma, Xianghong [2 ,3 ]
Mohammed, Afzal R. [1 ,3 ]
机构
[1] Aston Univ, Aston Sch Pharm, Birmingham B4 7ET, W Midlands, England
[2] Aston Univ, Sch Engn & Appl Sci, Birmingham B4 7ET, W Midlands, England
[3] Aston Univ, Aston Res Ctr Hlth Ageing, Birmingham B4 7ET, W Midlands, England
关键词
ATOMIC-FORCE MICROSCOPY; MICROCRYSTALLINE CELLULOSE; PARTICLE-SIZE; SOLID-STATE; COMPACTION PROPERTIES; PUNCH VELOCITY; CRYSTAL HABIT; THEOPHYLLINE; ADHESION; BEHAVIOR;
D O I
10.1371/journal.pone.0101369
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
The work investigates the adhesive/cohesive molecular and physical interactions together with nanoscopic features of commonly used orally disintegrating tablet (ODT) excipients microcrystalline cellulose (MCC) and D-mannitol. This helps to elucidate the underlying physico-chemical and mechanical mechanisms responsible for powder densification and optimum product functionality. Atomic force microscopy (AFM) contact mode analysis was performed to measure nano-adhesion forces and surface energies between excipient-drug particles (6-10 different particles per each pair). Moreover, surface topography images (100 nm(2)-10 mu m(2)) and roughness data were acquired from AFM tapping mode. AFM data were related to ODT macro/microscopic properties obtained from SEM, FTIR, XRD, thermal analysis using DSC and TGA, disintegration testing, Heckel and tabletability profiles. The study results showed a good association between the adhesive molecular and physical forces of paired particles and the resultant densification mechanisms responsible for mechanical strength of tablets. MCC micro roughness was 3 times that of D-mannitol which explains the high hardness of MCC ODTs due to mechanical interlocking. Hydrogen bonding between MCC particles could not be established from both AFM and FTIR solid state investigation. On the contrary, D-mannitol produced fragile ODTs due to fragmentation of surface crystallites during compression attained from its weak crystal structure. Furthermore, AFM analysis has shown the presence of extensive micro fibril structures inhabiting nano pores which further supports the use of MCC as a disintegrant. Overall, excipients (and model drugs) showed mechanistic behaviour on the nano/micro scale that could be related to the functionality of materials on the macro scale.
引用
收藏
页数:13
相关论文
共 59 条
[1]
Use of tablet tensile strength adjusted for surface area and mean interparticulate distance to evaluate dominating bonding mechanisms [J].
Adolfsson, Å ;
Gustafsson, C ;
Nyström, C .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1999, 25 (06) :753-764
[2]
Systematic Screening of Compressed ODT Excipients: Cellulosic Versus Non-Cellulosic [J].
Al-Khattawi, Ali ;
Iyire, Affiong ;
Dennison, Tom ;
Dahmash, Eman ;
Bailey, Clifford J. ;
Smith, Julian ;
Rue, Peter ;
Mohammed, Afzal R. .
CURRENT DRUG DELIVERY, 2014, 11 (04) :486-500
[3]
Compressed orally disintegrating tablets: excipients evolution and formulation strategies [J].
Al-khattawi, Ali ;
Mohammed, Afzal R. .
EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (05) :651-663
[4]
ALDERBORN G, 1988, ACTA PHARM SUEC, V25, P31
[5]
Alderborn G., 1996, Pharmaceutical Powder Compaction Technol- ogy
[6]
Ali A-K., 2012, DRUG DELIV LETT, V2, P195
[7]
THE EFFECT OF MOISTURE ON THE MECHANICAL AND POWDER FLOW PROPERTIES OF MICROCRYSTALLINE CELLULOSE [J].
AMIDON, GE ;
HOUGHTON, ME .
PHARMACEUTICAL RESEARCH, 1995, 12 (06) :923-929
[8]
Burger A, 2000, J PHARM SCI-US, V89, P457, DOI 10.1002/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO
[9]
2-G
[10]
Compaction behaviour and new predictive approach to the compressibility of binary mixtures of pharmaceutical excipients [J].
Busignies, V. ;
Leclerc, B. ;
Porion, P. ;
Evesque, P. ;
Couarraze, G. ;
Tchoreloff, P. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2006, 64 (01) :66-74